1. < Home

therapy

Considerations regarding maintenance therapy for acute myeloid leukemia in remission

Schiller GJ, Kustanovich V. Considerations regarding maintenance therapy for acute myeloid leukemia in remission. Expert Rev Anticancer Ther. 2024 Jan-Feb;24(1-2):15-20. doi: 10.1080/14737140.2024.2306164. Epub 2024 Feb[...]

By sjmartinez • February 13, 2024
ADS024, a single-strain live biotherapeutic product of Bacillus velezensis alleviates dextran sulfate-mediated colitis in mice, protects human colonic epithelial cells against apoptosis, and maintains epithelial barrier function

Irwin S, Chupina Estrada A, Nelson B, Bullock A, Limketkai B, Ho W, Acton S, Chesnel L, Koon HW. ADS024, a single-strain live biotherapeutic product[...]

By sjmartinez • January 25, 2024
Generalized Pustular Psoriasis: A Consensus Statement from the National Psoriasis Foundation

Armstrong AW, Elston CA, Elewski BE, Ferris LK, Gottlieb AB, Lebwohl MG; Medical Board of the National Psoriasis Foundation.. Generalized Pustular Psoriasis: A Consensus Statement[...]

By sjmartinez • October 15, 2023
Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design

Li YR, Ochoa CJ, Zhu Y, Kramer A, Wilson M, Fang Y, Chen Y, Singh T, Di Bernardo G, Zhu E, Lee D, Moatamed NA,[...]

By sjmartinez • October 10, 2023
Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3

Patolia H, Khan MS, Fonarow GC, Butler J, Greene SJ. Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3. J Am Coll Cardiol. 2023 Aug[...]

By sjmartinez • August 3, 2023
ADS024, a Bacillus velezensis strain, protects human colonic epithelial cells against C. difficile toxin-mediated apoptosis

Xie Y, Chupina Estrada A, Nelson B, Feng H, Pothoulakis C, Chesnel L, Koon HW. ADS024, a Bacillus velezensis strain, protects human colonic epithelial cells against C. difficiletoxin-mediated[...]

By sjmartinez • January 28, 2023